Stimulation of osteogenic activity in mesenchymal stem cells by FK506

Journal of Biomedical Materials Research - Part A

Volumn 86, Issue 1, 2008, Pages 235-243

  Dai, Wenda ^a   Dong, Jian ^a   Fang, Taolin ^a   Uemura, Toshimasa ^b  

^a FUDAN UNIVERSITY   (China)

^b NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

Author keywords

Dexamethasone; FK506; Mesenchymal stem cells; Osteogenesis; Tissue engineering

Indexed keywords

BIOTECHNOLOGY; BONE; CALCIUM; CELL CULTURE; CELLS; FLOWCHARTING; KETONES; MICROFLUIDICS; ORGANIC ACIDS; TISSUE ENGINEERING;

ALKALINE PHOSPHATASE (ALPASE); BONE MARROW (BM); CALCIUM DEPOSITION; CONCENTRATION (COMPOSITION); EXTRACELLULAR MATRIX FORMATION; GLYCEROPHOSPHATE; IN-VIVO; L ASCORBIC ACID; MESENCHYMAL STEM CELLS (MSCS); MRNA EXPRESSION; OSTEOCALCIN (OC); OSTEOGENIC ACTIVITY; OSTEOGENIC DIFFERENTIATION; TACROLIMUS (FK506);

TISSUE;

ALKALINE PHOSPHATASE; ASCORBIC ACID 2 PHOSPHATE; CALCIUM; DEXAMETHASONE; GLYCEROL 2 PHOSPHATE; MESSENGER RNA; OSTEOCALCIN; TACROLIMUS;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE DEVELOPMENT; BONE MARROW CELL; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STRUCTURE; CERAMICS; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; DRUG POTENTIATION; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; GENE EXPRESSION; IN VIVO STUDY; MALE; MESENCHYMAL STEM CELL; NONHUMAN; OSSIFICATION; RAT; SCANNING ELECTRON MICROSCOPY; STEM CELL TRANSPLANTATION;

ALKALINE PHOSPHATASE; ANIMALS; BONE MARROW CELLS; CALCIUM; CELL PROLIFERATION; IMMUNOSUPPRESSIVE AGENTS; MALE; MESENCHYMAL STEM CELLS; MICROSCOPY, ELECTRON, SCANNING; OSTEOCALCIN; OSTEOGENESIS; RATS; RATS, INBRED F344; TACROLIMUS; TISSUE ENGINEERING;

EID: 44849100777     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.31685     Document Type: Article

References (26)

1. Kino T, Hatanaka H, Hashimoto M, Nishiyama M, Goto T, Okuhara M, Kohsaka M, Aoki H, Imanaka H. FK-506, a novel immunosuppressant isolated from a Streptomyces. I. Fermentation, isolation, and physico-chemical and biological characteristics. J Antibiot 1987;40:1249-1255.
2. Kino T, Hatanaka H, Miyata S, Inamura N, Nishiyama M, Yajima T, Goto T, Okuhara M, Kohsaka M, Aoki H. FK-506, a novel immunosuppressant isolated from a Streptomyces. II. Immunosuppressive effect of FK-506 in vitro. J Antibiot 1987;40: 1256-1265.
3. Monegal A, Navasa M, Guanabens N, Peris P, Pons F, Martinez de Osaba MJ, Rimola A, Rodes J, Munoz-Gomez J. Bone mass and mineral metabolism in liver transplant patients treated with FK506 or cyclosporine A. Calcif Tissue Int 2001;68:83-86.
4. Ikebe S, Masumi S, Yano H, Fukunaga T, Shimizu K, Shin S. Immunosuppressive effect of tacrolimus (FK-506). Bone xenografts in rabbits. Acta Orthop Scand 1996;67:389-392.
5. Romero DF, Buchinsky FJ, Rucinski B, Cvetkovic M, Bryer HP, Liang XG, Ma YF, Jee WS, Epstein S. Rapamycin. A bone sparing immunosuppressant? J Bone Miner Res 1995;10: 760-768.
6. Inoue T, Kawamura I, Matsuo M, Aketa M, Mabuchi M, Seki J, Goto T. Lesser reduction in bone mineral density by the immunosuppressant. FK506, compared with cyclosporine in rats. Transplantation 2000;70:774-779.
7. Voggeneriter G, Assenmacher S, Kreuzfelder E, Wolf M, Kim MR, Nast-Kolb D, Schade FU. Immunosuppression with FK506 increases bone induction in demineralized isogeneic and xenogeneic bone matrix in the rat. J Bone Miner Res 2000;15:1825-1834.
8. Yoshikawa T, Nakajima H, Yamada E, Akahane M, Dohi Y, Ohgushi H, Tamai S, Ichijima K. In vivo osteogenic capability of cultured allogeneic bone in porous hydroxyapatite: Immunosuppressive and osteogenic potential of FK506 in vivo. J Bone Miner Res 2000;15:1147-1157.
9. Maniatopoulos C, Sodek J, Melcher AH. Bone formation in vitro by stromal cells obtained from bone marrow of young adult rats. Cell Tissue Res 1988;254:317-330.
10. Jaiswal N, Haynesworth SE, Caplan AI, Bruder SP. Osteogenic differentiation of purified, culture-expanded human mesenchymal stem cells in vitro. J Cell Biochem 1997;64:295-312.
11. Abe Y, Aida Y, Abe T, Hirofuji T, Anan H, Maeda K. Development of mineralized nodules in fetal rat mandibular osteogenic precursor cells: Requirement for dexamethasone but not for β-glycerophosphate. Calcif Tissue Int 2000;66:66-69.
12. Lennon DP, Haynesworth SE, Young RG, Dennis JE, Caplan AI. A chemically defined medium supports in vitro proliferation and maintains the osteochondral potential of rat marrow-derived mesenchymal stem cells. Exp Cell Res 1995,219: 211-222.
13. Hanada K, Dennis JE, Caplan AI. Stimulatory effects of basic fibroblast growth factor and bone morphogenetic protein-2 on osteogenic differentiation of rat bone marrow-derived mesenchymal stem cells. J Bone Miner Res 1997;12: 1606-1614.
14. Yoshikawa T, Ohgushi H, Tamai S. Immediate bone forming capability of prefabricated osteogenic hydroxyapatite. J Biomed Mater Res 1996;32:481-492.
15. Ohgushi H, Dohi Y, Katuda T, Tamai S, Tabata S, Suwa Y. In vitro bone formation by rat marrow cell culture. J Biomed Mater Res 1996;32:333-340.
16. Vermes C, Roebuck KA, Chandrasekaran R, Dobai JG, Jacobs JJ, Glant TT. Particulate wear debris activates protein tyrosine kinases and nuclear factor KB, which down-regulates type I collagen synthesis in human osteoblasts. J Bone Miner Res 2000;15:1756-1765.
17. Westergren-Thorsson G, Onnervik PO, Fransson LA, Malmstrom A. Proliferation of cultured fibroblasts is inhibited by L-iduronate- containing glycosaminoglycans. J Cell Physiol 1991;147:523-530.
18. Cassiede P, Dennis JE, Ma F, Caplan AI. Osteochondrogenic potential of marrow mesenchymal progenitor cells exposed to TGF-β 1 or PDGF-BB as assayed in vivo and in vitro. J Bone Miner Res 1996;11:1264-1273.
19. Davies JE, Chernecky R, Lowenberg B, Shiga A. Deposition and resorption of mineralized matrix in vitro by rat marrow cells. Cells Mater 1991;1:3-15.
20. Klein A. Tacrolimus rescue in liver transplant patients with refractory rejection or intolerance or malabsorption of cyclosporine. The US Multicenter FK506 Liver Study Group. Liver Transpl Surg 1999;5:502-508.
21. Jost SC, Doolabh VB, Mackinnon SE, Lee M, Hunter D. Acceleration of peripheral nerve regeneration following FK506 administration. Restor Neurol Neurosci 2000;17:39-44.
22. Isomoto S, Hattori K, Ohgushi H, Nakajima H, Tanaka Y, Takaura Y. Rapamycin as an inhibitor of osteogenic differentiation in bone marrow-derived mesenchymal stem cells. J Orthop Sci 2007;12:83-88.
23. Weinreb M, Shinar D, Rodan GA. Different pattern of alkaline phosphatase, osteopontin and osteocalcin expression in developing rat bone visualized by in situ hybridization. J Bone Miner Res 1990;5:831-842.
24. Chenoufi HL, Diamant M, Rieneck K, Lund B, Stein GS, Lian JB. Increased mRNA expression and protein secretion of interleukin-6 in primary human osteoblasts differentiated in vitro from rheumatoid and osteoarthritic bone. J Cell Biochem 2001;81:666-678.
25. Dong J, Kojima H, Uemura T, Kikuchi M, Tateishi T, Tanaka J. In vivo evaluation of a novel porous hydroxyapatite to sustain osteogenesis of transplanted bone marrow derived osteoblastic cells. J Biomed Mater Res 2001;57:208-216.
26. Ikedo D, Ohishi K, Yamauchi N, Kataoka M, Kido J, Nagata T. Stimulatory effects of phenytoin on osteoblastic differentiation of fetal rat calvaria cells in culture. Bone 1999;25: 653-660.